Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach. (Record no. 26739813)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01510 a2200445 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517132320.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201704s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1532-6535 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1002/cpt.558 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Arwood, M J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170425 |
245 00 - TITLE STATEMENT | |
Title | Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical pharmacology and therapeutics |
Date of publication, distribution, etc. | May 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 675-683 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Algorithms |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alleles |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anticoagulants |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytochrome P-450 CYP2C9 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Endpoint Determination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pharmacogenetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vitamin K Epoxide Reductases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Warfarin |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deng, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drozda, K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pugach, O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nutescu, E A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schmidt, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duarte, J D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cavallari, L H |
773 0# - HOST ITEM ENTRY | |
Title | Clinical pharmacology and therapeutics |
Related parts | vol. 101 |
-- | no. 5 |
-- | p. 675-683 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1002/cpt.558">https://doi.org/10.1002/cpt.558</a> |
Public note | Available from publisher's website |
No items available.